- Raised $18M Series C led by OTV, Aug 2020
- Raised $10M Series B led by OTV, Oct 2015
- Raised $4.5M Series A led by Medoc, Mar 2012
About
Medasense Biometrics is a medical device company that develops and produces breakthrough technology enabling clinicians to personalize pain management and avoid overmedication. Their flagship product, the PMD-200™ with its NOL® (Nociception Level) index, objectively monitors and quantifies a patient's pain response using a proprietary non-invasive sensor platform and artificial intelligence. The technology is utilized in operating rooms and critical care settings where patients are unable to communicate, aiming to improve patient outcomes, optimize pain management, and relieve suffering. Medasense also has a pipeline of cloud-based solutions for clinics and homes addressing additional markets and collaboration opportunities for long-term follow-up of pain treatment.
Funding history · 5 rounds · $33.5M total
Headcount over time
Q&A
- What is Medasense Biometrics' primary focus?
- Medasense Biometrics specializes in noninvasive pain-monitoring solutions, providing technology that helps clinicians optimize and personalize pain control while avoiding overmedication.
- What is Medasense Biometrics' flagship product?
- Medasense Biometrics' flagship product is the PMD-200, which uses its NOL index, artificial intelligence, and a proprietary noninvasive sensor platform to objectively monitor and quantify a patient's pain response.
- Where is the PMD-200 used?
- The PMD-200 is used to optimize pain management in operating rooms and critical care settings, particularly for patients who are unable to communicate their pain.
- Which company distributes the PMD-200 in Europe?
- Medtronic exclusively distributes Medasense Biometrics' PMD-200 in Europe.
- In which regions is the PMD-200 cleared for marketing?
- The PMD-200 is cleared for marketing in Canada, Latin America, Israel, and Australia.
- What is the total funding raised by Medasense Biometrics?
- Medasense Biometrics has raised a total of $33.5 million USD.
- When did Medasense Biometrics receive its most recent funding?
- Medasense Biometrics received funding in January 2025 from the BIRD Foundation.
- Which investors participated in Medasense Biometrics' September 2020 funding round?
- Sabadell Asabys VC and OTV participated in Medasense Biometrics' funding round in September 2020.
- How many employees does Medasense Biometrics have?
- Medasense Biometrics has 11-50 employees.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | medasense.com/ |
|---|---|
| linkedin.com/company/399874 | |
| facebook.com/MedasenseBiometricsLtd | |
| YouTube | youtube.com/channel/UCpSvFXsYshTsVS3TCmViRyg |
Identifiers & details
| Legal name | Medasense Biometrics Ltd. |
|---|---|
| Founded | 2008-6 |
| Employees (exact) | 27 |
| Offices | Longmont |
Radar intelligence
Patents
| EPO | 12 |
|---|
Web history (Wayback)
| Domain | medasense.com |
|---|
Certificate / subdomain footprint
| Subdomains | 18 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514156223 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-06-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — other (1), shares_capital (3), charge (1) |
| Registered address | החילזון 4 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-30 | שינוי בתקנון |
| 2025-12-29 | הקצאת מניות |
| 2025-12-16 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2025-12-15 | הגדלה של הון רשום |
| 2025-09-10 | סילוק שעבוד |